- Home
- CYTK vs SFBS Comparison
CYTK vs SFBS Comparison
Compare CYTK & SFBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYTK
- SFBS
- Stock Information
- Founded
- CYTK 1997
- SFBS 2005
- Country
- CYTK United States
- SFBS United States
- Employees
- CYTK 564
- SFBS N/A
- Industry
- CYTK Biotechnology: Pharmaceutical Preparations
- SFBS Major Banks
- Sector
- CYTK Health Care
- SFBS Finance
- Exchange
- CYTK Nasdaq
- SFBS Nasdaq
- Market Cap
- CYTK 5.8B
- SFBS 5.2B
- IPO Year
- CYTK 2004
- SFBS 2014
- Fundamental
- Price
- CYTK $48.87
- SFBS $85.85
- Analyst Decision
- CYTK Buy
- SFBS Hold
- Analyst Count
- CYTK 16
- SFBS 2
- Target Price
- CYTK $84.07
- SFBS $71.50
- AVG Volume (30 Days)
- CYTK 1.2M
- SFBS 266.2K
- Earning Date
- CYTK 11-06-2024
- SFBS 01-27-2025
- Dividend Yield
- CYTK N/A
- SFBS 1.40%
- EPS Growth
- CYTK N/A
- SFBS N/A
- EPS
- CYTK N/A
- SFBS 3.74
- Revenue
- CYTK $3,219,000.00
- SFBS $426,982,000.00
- Revenue This Year
- CYTK N/A
- SFBS N/A
- Revenue Next Year
- CYTK $795.25
- SFBS $18.05
- P/E Ratio
- CYTK N/A
- SFBS $22.96
- Revenue Growth
- CYTK N/A
- SFBS 0.15
- 52 Week Low
- CYTK $43.21
- SFBS $58.05
- 52 Week High
- CYTK $110.25
- SFBS $101.37
- Technical
- Relative Strength Index (RSI)
- CYTK 44.62
- SFBS 34.48
- Support Level
- CYTK $45.66
- SFBS $84.98
- Resistance Level
- CYTK $49.40
- SFBS $94.41
- Average True Range (ATR)
- CYTK 1.71
- SFBS 2.76
- MACD
- CYTK -0.20
- SFBS -1.44
- Stochastic Oscillator
- CYTK 50.79
- SFBS 7.13
About CYTK Cytokinetics Incorporated
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
About SFBS ServisFirst Bancshares Inc.
Servisfirst Bancshares Inc is a bank holding company. It originates commercial, consumer, and other loans and accepts deposits, provides electronic banking services, such as online and mobile banking, including remote deposit capture, delivers treasury and cash management services, and provides banking services to other financial institutions. The company offers services which include telephone banking, direct deposit, Internet banking, mobile banking, boxes, and automatic account transfers.